Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/20.500.12008/25952
Cómo citar
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | González-González, Rogelio | - |
dc.contributor.author | López-Verdín, Sandra | - |
dc.contributor.author | Lavalle-Carrasco, Jesús | - |
dc.contributor.author | Molina-Frechero, Nelly | - |
dc.contributor.author | Isiordia-Espinoza, Mario | - |
dc.contributor.author | Carreón Burciaga, Ramón Gil | - |
dc.contributor.author | Bologna-Molina, Ronell | - |
dc.date.accessioned | 2020-11-25T14:37:26Z | - |
dc.date.available | 2020-11-25T14:37:26Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | González-González, R, López-Verdín, S, Lavalle-Carrasco, J, y otros. "Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review". World Journal Clinical Oncology. [en línea] January 24; 11(1): 31-42, 2020. DOI: 10.5306/wjco.v11.i1.31 | es |
dc.identifier.issn | 2218-4333 (online) | - |
dc.identifier.uri | https://hdl.handle.net/20.500.12008/25952 | - |
dc.description.abstract | Ameloblastomas are common benign epithelial odontogenic neoplasms that present an aggressive and unpredictable behavior that may modify treatment strategies. Different signaling pathways that participate in the progression of these tumors have been identified. B-raf proto-oncogene serine/threonine kinase (BRAF) is a protein involved in the behavior of ameloblastomas, and it is related to many cell mechanisms. BRAF gene mutations have been identified in ameloblastomas, of which the BRAF V600E (valine substituted by glutamic acid at amino acid 600) mutation has been the most common and can be present concomitantly with other mutations that may be involved in its behavior. Targeted therapies have been used as an alternative in the case of resistance or contraindications to conventional treatments. | en |
dc.format.mimetype | application/pdf | en |
dc.language.iso | en | en |
dc.relation.ispartof | World Journal Clinical Oncology, January 24; 11(1): 31-42, 2020 | en |
dc.rights | Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014) | es |
dc.subject | Ameloblastoma | es |
dc.subject | B-raf proto-oncogene serine/threonine kinase | en |
dc.subject | B-raf protooncogene serine/threonine kinase V600E | en |
dc.subject | Targeted therapies | en |
dc.subject | Additional mutations | en |
dc.title | Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review | en |
dc.type | Artículo | es |
dc.contributor.filiacion | González-González Rogelio | - |
dc.contributor.filiacion | López-Verdín Sandra | - |
dc.contributor.filiacion | Lavalle-Carrasco Jesús | - |
dc.contributor.filiacion | Molina-Frechero Nelly, Universidad de la República (Uruguay). Facultad de Odontología | - |
dc.contributor.filiacion | Isiordia-Espinoza Mario | - |
dc.contributor.filiacion | Carreón-Burciaga Ramón G. | - |
dc.contributor.filiacion | Bologna-Molina Ronell | - |
dc.rights.licence | Licencia Creative Commons Atribución - No Comercial (CC - By-NC 4.0) | es |
dc.identifier.doi | DOI: 10.5306/wjco.v11.i1.31 | - |
Aparece en las colecciones: | Publicaciones académicas y científicas 2020- - Facultad de Odontología |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | ||
---|---|---|---|---|---|
Current concepts 2020.pdf | 2,15 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons